Synthetic protein molecules will be designed with desired functions to meet practical needs in bio-medical and other fields, based on available data from 3D-structures, chemistry, biology and medicine. 

The engineered proteins can be constructed with DNA-recombination technologies and biochemical methodology and validated by fundamental characterizations with methods of biochemistry, biotechnology, oncology, virology, and immunology, as well as by preclinical studies and clinical trials.